Results 131 to 140 of about 7,734 (200)

Rewriting paracelsus: linking chemical assessment to public health. [PDF]

Front Toxicol
Fernandez-Agudo A, González-Caballero MDC, Tarazona JV.   +2 more
europepmc   +1 more source

NGRA in Cosmetic Safety: Moving From the Frameworks and Case Studies to Wide Adoption. [PDF]

Curr Opin Toxicol
Rusyn I, Chiu WA, Dent M, Middleton A.
europepmc   +1 more source

Editorial: The safety assessment of novel foods and new nutrient sources. [PDF]

Front Toxicol
Pozzo L, Glymenaki M.
europepmc   +1 more source

Kinetic Benefit(s) of Allosteric Receptor Blockade by Positive Allosteric Modulator Antagonists. [PDF]

ACS Pharmacol Transl Sci
Vauquellin G, Kenakin T.
europepmc   +1 more source

Filling the mechanistic and methodological gaps for predicting cytokine release syndrome in humans. [PDF]

Front Pharmacol
Clerbaux LA, Alb M, Fogal B, Hartung T, Hench VK, Morgan H, Gavins FNE, Lindeman B, Margiotta-Casaluci L, Ostaszewski M, Reiche K, Sachana M, Wittwehr C, Sewald K.   +13 more
europepmc   +1 more source

Defining benchmarking in the context of safety assessment of personal care and cosmetic products using New Approach Methodologies. [PDF]

NAM J
Huang H, Costin GE.
europepmc   +1 more source

Accelerating Cosmetic Innovation Through Next-Generation Computational Toxicology: From Structural Alerts to Molecular Dynamics and Artificial Intelligence for Skin Sensitization Assessment. [PDF]

Toxics
Quintero-Trujillo TE, Diaz-Rojas L, Andrade H, Alfonso-Romero P.   +3 more
europepmc   +1 more source

Need for NAMs: A systematic evidence synthesis revealing over half a century of drug development failure. [PDF]

NAM J
Filipova D, Boomgaarden W, Fox L, Knight A, Lickiss B, Maass C, Neumann G, Watkins J, Herrmann K, Ewart L, Gossmann M, Ritskes-Hoitinga M, Zietek T.   +12 more
europepmc   +1 more source

Thin Nevus-Associated Melanoma: Beyond MIA Score Risk Stratification. [PDF]

Cancers (Basel)
Venturi F, Orlando ML, Corti B, Marchese PV, Comito F, Melotti B, Magnaterra E, Scotti B, Alessandrini AM, Veneziano L, Cama EM, Dika E.   +11 more
europepmc   +1 more source

Secondary Pharmacology Targets for Pediatric Developmental Safety Assessment of New Drugs: Clinical Pharmacology Considerations. [PDF]

Clin Pharmacol Ther
Burckart GJ, Samuels S, Abdel-Rahman SM, Abulwerdi G, Fletcher E, Mohamoud MA, Srinivasan A, Tatonetti N, Racz R.   +8 more
europepmc   +1 more source